Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area

References

• Jönsson B. Cost benefit of treating hypertension. J Hum Hypertens 1994;12:65–70.
   Google Scholar
• Johannesson M. The cost-effectiveness of hypertension treatment in Sweden: An analysis of the criteria for intervention and choice of drug treatment. J Hum Hypertens 1999;10:23–6.
   Google Scholar
• Stowasser M, Gordon RD. Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2003;17:591–605.
   PubMed Web of Science ®Google Scholar
• Young WF Jr. Primary aldosteronism: A common and curable form of hypertension. Cardiol Rev 1999;7:207–14.
   PubMedGoogle Scholar
• Stowasser M, Gordon RD. Primary aldosteronism: From genesis to genetics. Trends Endocrinolol Metab 2003;14:310–7.
   PubMed Web of Science ®Google Scholar
• Young WF. Primary aldosteronism: Renaissance of a syndrome. Clin Endocrinolol 2007;66:607–18.
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, . Case detection, diagnosis and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinolo Metab 2008;93:3266–81.
   PubMed Web of Science ®Google Scholar
• Mattson C, Young WF jr. Primary aldosteronism: Diagnostic and treatment strategies. Nat Clin Pract Nephrol 2006;2:198–208.
   PubMedGoogle Scholar
• Conn JW. Primary aldosteronism, a new clinical entity. J Lab Clin Med 1955;45:661–4.
   PubMed Web of Science ®Google Scholar
• Lim PO, Brennan G, Shiels P. Unexpectedly high prevalence of primary hyper-aldosteronism in a hypertensive population in Dundee. J Endocrinol 1998;156:22.
   Google Scholar
• Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary hyperaldosteronism in a primary-care population. Lancet 1999;353:40.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, . Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centres from five continents. J Clin Endocrinolo Metab 2004;89:1045–50.
   PubMed Web of Science ®Google Scholar
• Westerdahl C, Bergenfelz A, Isaksson A, Wihl A, Nerbrand C, Valdemarsson S. High frequency of primary aldosteronism among hypertensive patients from a primary care area in Sweden. Scand J Prim Health Care 2006;24:154–9.
   PubMed Web of Science ®Google Scholar
• Gordon RD, Stowasser M. Primary aldosteronism: The case for screening. Nat Clin Pract Nephrol 2007;3:582–3.
   PubMedGoogle Scholar
• Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Smithers BM. High rate of detection of primary aldosteronism, including surgically treatable forms, after “non selective” screening of hypertensive patients. J Hypertens 2003;2:2149–57.
   Google Scholar
• Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism in unselected hypertensives: A prospective study based on the use of an aldosterone/renin ratio as a screening test. Hypertens Rev 2007;30:111–17.
   PubMed Web of Science ®Google Scholar
• Anis AY, White WB, Mansoor GA. Hyperaldosteronsim is a common cause of secondary hypertension missed by primary care physicians and associated with normokalemia. Am J Hypertens 1998;11:199A.
   Google Scholar
• Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol 2002;57:457–65.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Rossi E, Pavan E, Rosati N, Zecchel R, Semplicini A, . Screening for primary aldosteronsism with a logistic multivariate discriminant analysis. Clin endocrinol (Oxf.) 1998;49:713–23.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Dluhy RG, Giachetti G, Boscaro M, Veglio F, Stewart PM. Diagnosis of primary aldosteronism: From screening to subtype differentiation. Trends Endocrinol Metab 2005;16:114–9.
   PubMed Web of Science ®Google Scholar
• Doppman J, Gill J. Hyperaldosteronism: Sampling adrenal veins. Radiology 1996;198:309–12.
   PubMed Web of Science ®Google Scholar
• Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243–8.
   PubMed Web of Science ®Google Scholar
• Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008;168:80–5.
   PubMedGoogle Scholar
• Mosso L, Carvajal C, González A, Barraza A, Avila F, Montero J, Huete A, . Primary aldosteronism and hypertensive disease. Hypertension 2003;42:161–5.
   PubMed Web of Science ®Google Scholar
• Stowasser M, Gordon RD. Primary aldosteronism: Careful investigation is essential and rewarding. Molecular Cellular Endocrinolol 2004;217:33–9.
   PubMed Web of Science ®Google Scholar
• Seiler L, Rump L, Schulte-Mönting J, Slawik M, Borm K, Pavenstädt H, . Diagnosis of primary aldosteronism: Value of different screening parameters and influence of antihypertensive drugs. Eur J Endocrinol 2004;150:329–37.
   PubMed Web of Science ®Google Scholar
• Hennings J, Andreasson S, Botling J, Hägg A, Sundin A, Hellman P. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism. Langenbeck's Arch Surg 2009;395:133–7.
   PubMed Web of Science ®Google Scholar
• Campagnacci R, Crosta F, De Sanctis A, Baldarelli M, Giacchetti G, Paganini AM, . Long-term results of laparoscopic adrenalectomy for primary aldosteronism. J Endocrinol Invest 2009;32:57–62.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocrine J 2006;10:1507–19.
   Google Scholar
• Montoni VM, Young W Jr. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism: A systematic review of literature. Endocrionol Metab Clin Am 2002;31:619–32.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Pessina, Heagerty AM, Primary aldosteronism: An update on screening, diagnosis and treatment. J Hypertens 2008;26:613–21.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Monticone S, Bertello C, Tizzani D, Iannaccone A, Crudo V, Veglio F. Evaluation of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 2010b;17:188–93.
   PubMed Web of Science ®Google Scholar